Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Mirum Pharmaceuticals, Inc.(MIRM) | 7,679,684 | 7,679,684 | 0 | $899.06M | $656.46M | 16.29% | -$242.60M |
| Newamsterdam Pharma Company ORDINARY SHARES | 18,088,902 | 18,988,902 | +900,000 | $613.03M | $461.81M | 11.46% | -$151.22M |
| Erasca, Inc.(ERAS) | 24,975,188 | 29,475,188 | +4,500,000 | $457.55M | $432.11M | 10.72% | -$25.44M |
| MBX Biosciences, Inc.(MBX) | 6,652,013 | 6,652,013 | 0 | $367.19M | $389.94M | 9.67% | +$22.75M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 9,874,511 | 9,874,511 | 0 | $258.91M | $260.98M | 6.48% | +$2.07M |
| Maze Therapeutics, Inc.(MAZE) | 5,032,915 | 5,282,915 | +250,000 | $150.18M | $143.59M | 3.56% | -$6.59M |
| Trevi Therapeutics, Inc.(TRVI) | 9,939,447 | 9,539,147 | -400,300 | $185.37M | $136.60M | 3.39% | -$48.77M |
| Krystal Biotech, Inc.(KRYS) | 481,307 | 391,319 | -89,988 | $178.89M | $130.14M | 3.23% | -$48.75M |
| Palvella Therapeutics, Inc.(PVLA) | 882,400 | 882,400 | 0 | $134.85M | $121.71M | 3.02% | -$13.14M |
| Attovia Therapeutics Inc | 0 | 7,046,271 | +7,046,271 | $0 | $120.77M | 3.00% | +$120.77M |
| Braveheart Bio Inc | 0 | 5,267,321 | +5,267,321 | $0 | $106.40M | 2.64% | +$106.40M |
| Phathom Pharmaceuticals Inc | 12,466,489 | 12,466,489 | 0 | $135.26M | $91.01M | 2.26% | -$44.26M |
| Parabilis Medicines Inc | 1,920,805 | 2,330,750 | +409,945 | $52.57M | $75.26M | 1.87% | +$22.69M |
| Dyne Therapeutics, Inc.(DYN) | 3,153,082 | 3,853,082 | +700,000 | $70.03M | $62.07M | 1.54% | -$7.96M |
| Achieve Life Science Inc | 7,614,836 | 7,614,836 | 0 | $49.72M | $61.60M | 1.53% | +$11.88M |
| MannKind Corporation(MNKD) | 6,600,000 | 15,755,491 | +9,155,491 | $28.12M | $61.45M | 1.52% | +$33.33M |
| Disc Medicine, Inc.(IRON) | 1,354,852 | 934,852 | -420,000 | $99.09M | $61.20M | 1.52% | -$37.90M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 728,644 | 720,338 | -8,306 | $45.86M | $56.63M | 1.40% | +$10.76M |
| Vor Biopharma Inc.(VOR) | 2,543,939 | 2,743,939 | +200,000 | $46.83M | $52.35M | 1.30% | +$5.52M |
| Ascendis Pharma A/S(ASND) | 0 | 225,155 | +225,155 | $0 | $51.30M | 1.27% | +$51.30M |
| Zai Lab LimitedADR(ZLAB) | 1,902,320 | 1,902,320 | 0 | $36.14M | $50.11M | 1.24% | +$13.96M |
| Aclaris Therapeutics Inc | 4,925,374 | 8,729,516 | +3,804,142 | $26.06M | $45.92M | 1.14% | +$19.86M |
| Aura Biosciences Inc | 7,100,000 | 7,100,000 | 0 | $50.41M | $44.59M | 1.11% | -$5.82M |
| Allogene Therapeutics Inc | 22,446,668 | 22,446,668 | 0 | $46.69M | $35.91M | 0.89% | -$10.77M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 4,009,240 | 4,009,240 | 0 | $40.09M | $33.40M | 0.83% | -$6.70M |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 900,080 | +900,080 | $0 | $29.17M | 0.72% | +$29.17M |
| Acadia Pharmaceuticals Inc | 1,438,198 | 1,438,198 | 0 | $36.39M | $28.98M | 0.72% | -$7.41M |
| Shattuck Labs Inc | 3,750,000 | 3,750,000 | 0 | $26.02M | $25.57M | 0.63% | -$450.0K |
| Immunocore Holdings plcADS(IMCR) | 484,782 | 829,752 | +344,970 | $15.39M | $25.13M | 0.62% | +$9.74M |
| Design Therapeutics Inc | 1,809,854 | 1,809,854 | 0 | $26.19M | $22.75M | 0.56% | -$3.44M |
| Evolus Inc | 2,630,665 | 2,630,665 | 0 | $18.26M | $21.05M | 0.52% | +$2.79M |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 1,069,959 | +1,069,959 | $0 | $19.49M | 0.48% | +$19.49M |
| Relay Therapeutics, Inc.(RLAY) | 1,015,693 | 1,015,693 | 0 | $19.00M | $18.33M | 0.45% | -$670.4K |
| Lexeo Therapeutics Inc | 4,824,725 | 4,824,725 | 0 | $22.46M | $16.31M | 0.40% | -$6.15M |
| Valneva SeADS | 2,291,666 | 2,291,666 | 0 | $11.99M | $14.17M | 0.35% | +$2.19M |
| Kailera Therapeutics Inc | 1,100,000 | 1,200,000 | +100,000 | $24.23M | $13.70M | 0.34% | -$10.53M |
| Monte Rosa Therapeutics Inc | 1,000,000 | 1,000,000 | 0 | $24.20M | $11.93M | 0.30% | -$12.27M |
| Oric Pharmaceuticals Inc | 0 | 751,672 | +751,672 | $0 | $10.13M | 0.25% | +$10.13M |
| Autolus Therapeutics LtdADS | 4,447,910 | 4,447,910 | 0 | $7.12M | $8.63M | 0.21% | +$1.51M |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 500,333 | 500,333 | 0 | $10.69M | $6.33M | 0.16% | -$4.36M |
| Savara Inc.(SVRA) | 9,720,852 | 1,113,752 | -8,607,100 | $59.88M | $5.75M | 0.14% | -$54.13M |
| Xilio Therapeutics Inc | 422,505 | 422,505 | 0 | $4.05M | $3.82M | 0.09% | -$223.9K |
| Tcgx Acquisition CorpCL A | 0 | 300,000 | +300,000 | $0 | $3.75M | 0.09% | +$3.75M |
| Ibio Inc | 1,953,467 | 1,953,467 | 0 | $3.42M | $2.31M | 0.06% | -$1.11M |
| Alkermes plcSHS(ALKS) | 700,647 | 0 | -700,647 | $36.71M | $0 | — | -$36.71M |
| Ascendis Pharma A/SADR(ASND) | 225,155 | 0 | -225,155 | $60.05M | $0 | — | -$60.05M |
| BridgeBio Pharma, Inc.(BBIO) | 1,548,139 | 0 | -1,548,139 | $115.31M | $0 | — | -$115.31M |
| Cytokinetics, Incorporated(CYTK) | 1,159,879 | 0 | -1,159,879 | $98.81M | $0 | — | -$98.81M |